Video
Recently Presented Data Informing the Treatment of Patients with Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia
Author(s):
The panelists review highly anticipated results from the E1910 trial assessing combination blinatumomab/consolidation chemotherapy in patients with Philadelphia chromosome-negative ALL.
Video Player is loading.
Related Videos
Reflections and Future Directions in R/R ALL
Outpatient CAR T Therapy and Expanding Access
Health Care Resource Utilization and Transition of Care
Treatment Overview in Later-Stage Relapsed/Refractory Multiple Myeloma
Emerging Data on BTK Inhibitor Degraders and Bispecifics in R/R CLL: Updated Results at ASH 2024
Exploring Data of PI3K/AKT/mTOR Inhibitors in HER2– mBC
The Evolving Landscape: CAR T and Future Therapies in Early-Stage R/R Myeloma
Genotype-Directed Therapies for HR+/HER2– Advanced Breast Cancer
Real-World Observations With Pirtobrutinib and New Data From the BRUIN CLL-321 Trial at ASH 2024
Reflections and Future Directions in CLL Management
Related Content
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
